181 related articles for article (PubMed ID: 37119865)
1. Design of disintegrable nanoassemblies to release multiple small-sized nanoparticles.
Zhu D; Yan H; Zhou Y; Nack LM; Liu J; Parak WJ
Adv Drug Deliv Rev; 2023 Jun; 197():114854. PubMed ID: 37119865
[TBL] [Abstract][Full Text] [Related]
2. Stimuli-responsive nanoassemblies for targeted delivery against tumor and its microenvironment.
Sia CS; Lim HP; Tey BT; Goh BH; Low LE
Biochim Biophys Acta Rev Cancer; 2022 Sep; 1877(5):188779. PubMed ID: 35977690
[TBL] [Abstract][Full Text] [Related]
3. Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine.
Du JZ; Li HJ; Wang J
Acc Chem Res; 2018 Nov; 51(11):2848-2856. PubMed ID: 30346728
[TBL] [Abstract][Full Text] [Related]
4. Stimuli-responsive polypeptide nanoassemblies: Recent progress and applications in cancer nanomedicine.
Song Y; Ding Y; Dong CM
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Mar; 14(2):e1742. PubMed ID: 34310063
[TBL] [Abstract][Full Text] [Related]
5. Core-matched nanoassemblies for targeted co-delivery of chemotherapy and photosensitizer to treat drug-resistant cancer.
Jiang D; Xu M; Pei Y; Huang Y; Chen Y; Ma F; Lu H; Chen J
Acta Biomater; 2019 Apr; 88():406-421. PubMed ID: 30763634
[TBL] [Abstract][Full Text] [Related]
6. Rapid pH-responsive self-disintegrating nanoassemblies balance tumor accumulation and penetration for enhanced anti-breast cancer therapy.
Li J; Wang Y; Xu C; Yu Q; Wang X; Xie H; Tian L; Qiu Y; Guo R; Lu Z; Li M; He Q
Acta Biomater; 2021 Oct; 134():546-558. PubMed ID: 33882357
[TBL] [Abstract][Full Text] [Related]
7. Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance.
Ge Z; Liu S
Chem Soc Rev; 2013 Sep; 42(17):7289-325. PubMed ID: 23549663
[TBL] [Abstract][Full Text] [Related]
8. Stimuli-responsive polymeric nanoparticles for nanomedicine.
Crucho CI
ChemMedChem; 2015 Jan; 10(1):24-38. PubMed ID: 25319803
[TBL] [Abstract][Full Text] [Related]
9. [The development of novel tumor targeting delivery strategy].
Gao HL; Jiang XG
Yao Xue Xue Bao; 2016 Feb; 51(2):272-80. PubMed ID: 29856581
[TBL] [Abstract][Full Text] [Related]
10. Prodrug-based nanoparticulate drug delivery strategies for cancer therapy.
Luo C; Sun J; Sun B; He Z
Trends Pharmacol Sci; 2014 Nov; 35(11):556-66. PubMed ID: 25441774
[TBL] [Abstract][Full Text] [Related]
11. Ultrasound-mediated nano drug delivery for treating cancer: Fundamental physics to future directions.
Moradi Kashkooli F; Jakhmola A; Hornsby TK; Tavakkoli JJ; Kolios MC
J Control Release; 2023 Mar; 355():552-578. PubMed ID: 36773959
[TBL] [Abstract][Full Text] [Related]
12. Tumor microenvironment-responsive dynamic inorganic nanoassemblies for cancer imaging and treatment.
Yang Y; Wu H; Liu B; Liu Z
Adv Drug Deliv Rev; 2021 Dec; 179():114004. PubMed ID: 34662672
[TBL] [Abstract][Full Text] [Related]
13. Targeting endothelial permeability in the EPR effect.
Lahooti B; Akwii RG; Zahra FT; Sajib MS; Lamprou M; Alobaida A; Lionakis MS; Mattheolabakis G; Mikelis CM
J Control Release; 2023 Sep; 361():212-235. PubMed ID: 37517543
[TBL] [Abstract][Full Text] [Related]
14. Polymer-Graphene Nanoassemblies and their Applications in Cancer Theranostics.
Sivakumar PM; Islami M; Zarrabi A; Khosravi A; Peimanfard S
Anticancer Agents Med Chem; 2020; 20(11):1340-1351. PubMed ID: 31746307
[TBL] [Abstract][Full Text] [Related]
15. Small-Molecule Prodrug Nanoassemblies: An Emerging Nanoplatform for Anticancer Drug Delivery.
Li G; Sun B; Li Y; Luo C; He Z; Sun J
Small; 2021 Dec; 17(52):e2101460. PubMed ID: 34342126
[TBL] [Abstract][Full Text] [Related]
16. The Smart Dual-Stimuli Responsive Nanoparticles for Controlled Anti-Tumor Drug Release and Cancer Therapy.
Wu F; Qiu F; Wai-Keong SA; Diao Y
Anticancer Agents Med Chem; 2021; 21(10):1202-1215. PubMed ID: 32972353
[TBL] [Abstract][Full Text] [Related]
17. Size and charge dual-transformable mesoporous nanoassemblies for enhanced drug delivery and tumor penetration.
Chen L; Zhao T; Zhao M; Wang W; Sun C; Liu L; Li Q; Zhang F; Zhao D; Li X
Chem Sci; 2020 Feb; 11(10):2819-2827. PubMed ID: 34084342
[TBL] [Abstract][Full Text] [Related]
18. Stimuli-responsive clustered nanoparticles for improved tumor penetration and therapeutic efficacy.
Li HJ; Du JZ; Du XJ; Xu CF; Sun CY; Wang HX; Cao ZT; Yang XZ; Zhu YH; Nie S; Wang J
Proc Natl Acad Sci U S A; 2016 Apr; 113(15):4164-9. PubMed ID: 27035960
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticles for Cancer Targeting: Current and Future Directions.
Swain S; Sahu PK; Beg S; Babu SM
Curr Drug Deliv; 2016; 13(8):1290-1302. PubMed ID: 27411485
[TBL] [Abstract][Full Text] [Related]
20. Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy.
Raj S; Khurana S; Choudhari R; Kesari KK; Kamal MA; Garg N; Ruokolainen J; Das BC; Kumar D
Semin Cancer Biol; 2021 Feb; 69():166-177. PubMed ID: 31715247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
